Heart failure drug levosimendan tested for long-term safety in 35 patients
Disease control
Completed
This study looked at the safety of using levosimendan over a longer period in people who have both pulmonary hypertension and heart failure with preserved ejection fraction. 35 patients who had already been in a related study received the drug and were monitored for side effects.…
Phase: PHASE2 • Sponsor: Tenax Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC